Literature DB >> 18595126

Minimal hepatic encephalopathy matters in daily life.

Jasmohan S Bajaj.   

Abstract

Minimal hepatic encephalopathy is a neuro-cognitive dysfunction which occurs in an epidemic proportion of cirrhotic patients, estimated as high as 80% of the population tested. It is characterized by a specific, complex cognitive dysfunction which is independent of sleep dysfunction or problems with overall intelligence. Although named "minimal", minimal hepatic encephalopathy (MHE) can have a far-reaching impact on quality of life, ability to function in daily life and progression to overt hepatic encephalopathy. Importantly, MHE has a profound negative impact on the ability to drive a car and may be a significant factor behind motor vehicle accidents. A crucial aspect of the clinical care of MHE patients is their driving history, which is often ignored in routine care and can add a vital dimension to the overall disease assessment. Driving history should be an integral part of care in patients with MHE. The lack of specific signs and symptoms, the preserved communication skills and lack of insight make MHE a difficult condition to diagnose. Diagnostic strategies for MHE abound, but are usually limited by financial, normative or time constraints. Recent studies into the inhibitory control and critical flicker frequency tests are encouraging since these tests can increase the rates of MHE diagnosis without requiring a psychologist. Although testing for MHE and subsequent therapy is not standard of care at this time, it is important to consider this in cirrhotics in order to improve their ability to live their life to the fullest.

Entities:  

Mesh:

Year:  2008        PMID: 18595126      PMCID: PMC2719222          DOI: 10.3748/wjg.14.3609

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  68 in total

1.  Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

Authors:  Gerald Kircheis; Matthias Wettstein; Lars Timmermann; Alfons Schnitzler; Dieter Häussinger
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

2.  Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis.

Authors:  A Das; R K Dhiman; V A Saraswat; M Verma; S R Naik
Journal:  J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 4.029

3.  Can we ignore minimal hepatic encephalopathy any longer?

Authors:  Asif M Qadri; Ben O Ogunwale; Kevin D Mullen
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

4.  High prevalence of sleep disturbance in cirrhosis.

Authors:  J Córdoba; J Cabrera; L Lataif; P Penev; P Zee; A T Blei
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

5.  Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus.

Authors:  M Uribe; M Dibildox; S Malpica; E Guillermo; A Villallobos; L Nieto; F Vargas; G Garcia Ramos
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

6.  Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.

Authors:  M Romero-Gómez; F Boza; M S García-Valdecasas; E García; J Aguilar-Reina
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

7.  Insight and danger in Alzheimer's disease.

Authors:  S E Starkstein; R Jorge; R Mizrahi; J Adrian; R G Robinson
Journal:  Eur J Neurol       Date:  2007-04       Impact factor: 6.089

8.  Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment.

Authors:  Montserrat Ferrer; Juan Córdoba; Olatz Garin; Gemma Olivé; Montserrat Flavià; Victor Vargas; Rafael Esteban; Jordi Alonso
Journal:  Liver Transpl       Date:  2006-01       Impact factor: 5.799

9.  Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis.

Authors:  Samuel H Sigal; Carmen M Stanca; Nickolas Kontorinis; Carol Bodian; Elizabeth Ryan
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

10.  Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.

Authors:  Robert J Fontana; Linas A Bieliauskas; Karen L Lindsay; Carla Back-Madruga; Elizabeth C Wright; Kristin K Snow; Anna S F Lok; Ziad Kronfol; Latha Padmanabhan
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

View more
  48 in total

Review 1.  Advances in the evaluation and management of minimal hepatic encephalopathy.

Authors:  Jennifer Y Montgomery; Jasmohan S Bajaj
Journal:  Curr Gastroenterol Rep       Date:  2011-02

2.  Motor vehicle accidents: how should cirrhotic patients be managed?

Authors:  Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

3.  Differences in cognitive function between patients with viral and alcoholic compensated liver cirrhosis.

Authors:  Yunhyeong Lee; Chulho Kim; Ki Tae Suk; Hui Chul Choi; Chang Seok Bang; Jai Hoon Yoon; Gwang Ho Baik; Dong Joon Kim; Min Uk Jang; Jong Hee Sohn
Journal:  Metab Brain Dis       Date:  2015-11-12       Impact factor: 3.584

4.  Hepatobiliary quiz-10 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-06

5.  Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.

Authors:  Jatinderpal Singh; Barjesh Chander Sharma; Vinod Puri; Sanjeev Sachdeva; Siddharth Srivastava
Journal:  Metab Brain Dis       Date:  2017-01-09       Impact factor: 3.584

6.  Hepatic encephalopathy therapy: An overview.

Authors:  Oliviero Riggio; Lorenzo Ridola; Chiara Pasquale
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-04-06

7.  Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease.

Authors:  Mette Munk Lauridsen; Peter Jepsen; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2011-04-12       Impact factor: 3.584

8.  An association between dietary habits and traffic accidents in patients with chronic liver disease: A data-mining analysis.

Authors:  Takumi Kawaguchi; Takuro Suetsugu; Shyou Ogata; Minami Imanaga; Kumiko Ishii; Nao Esaki; Masako Sugimoto; Jyuri Otsuyama; Ayu Nagamatsu; Eitaro Taniguchi; Minoru Itou; Tetsuharu Oriishi; Shoko Iwasaki; Hiroko Miura; Takuji Torimura
Journal:  Biomed Rep       Date:  2016-03-23

Review 9.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

10.  Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).

Authors:  Mircea Alexandru Badea; Vasile Liviu Drug; Mihaela Dranga; Otilia Gavrilescu; Gabriela Stefanescu; Iolanda Popa; Catalina Mihai; Cristina Cijevschi-Prelipcean
Journal:  Metab Brain Dis       Date:  2016-07-27       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.